Literature DB >> 36156766

Relationship between Trace Elements and Matrix Metalloproteinases 2 and 9 and their Tissue Inhibitors in Medullary Thyroid Carcinoma.

Héctor Vázquez-Lorente1, Duško M Dundjerović2, Svetislav B Tatić2, Sara Rodríguez-Menéndez3, Héctor González-Iglesias3,4, Cláudio M Gomes5,6, Ivan R Paunović7,8, Vesna V Dragutinović9.   

Abstract

Medullary Thyroid Carcinoma (MTC) constitutes around 5% of all thyroid cancers. Trace elements assessment has emerged as a useful strategy in the diagnostics of MTC combined with Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Matrix Metalloproteinases (TIMPs) analysis. The aim of this study was to compare the presence and content of trace elements (i.e., Copper (Cu), Zinc (Zn), Iron (Fe), and Manganese (Mn)) in MTC with respect to control samples and their potential relationship with markers of MTC in tissues. The study included 26 patients who had undergone thyroidectomy, due to the diagnosis of MTC and 17 patients as control. We combined tumour pathology and staging, immunohistochemical analysis of calcitonin, MMPs, and TIMPs, with analytical biochemistry using Inductively Coupled Plasma - Mass Spectrometry (ICP-MS) to determine the levels of trace elements. No differences by MTC type for MMPs and their TIPMs, although strong TIMP-1 and TIMP-2 immunohistochemical expression of MTC were unveiled. Additionally, Zn, Fe, and Mn tended to be decreased, and Cu to be increased in samples presenting MTC with respect to controls. Moreover, Zn was the unique trace element which seemed to be correlated with MMPs and TIMPs. Trace elements such as Zn, Fe, and Mn are decreased in tissues affected by MTC. In addition, Zn may be the trace element which saves more relationship with the proportion and intensity of MMPs, being considered altogether useful biomarkers of MTC. We therefore suggest the analysis of novel and traditional markers of MTC as a novel approach in this pathology.
© 2022. The Author(s).

Entities:  

Keywords:  Calcitonin; Matrix metalloproteinases (MMPs); Medullary thyroid carcinoma; Tissue inhibitors of matrix metalloproteinases (TIMPs); Trace elements

Year:  2022        PMID: 36156766     DOI: 10.1007/s12011-022-03431-z

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   4.081


  24 in total

1.  The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients.

Authors:  Guillaume Chambon; Caroline Alovisetti; Catherine Idoux-Louche; Christophe Reynaud; Michel Rodier; Anne-Marie Guedj; Héliette Chapuis; Jean-Gabriel Lallemant; Benjamin Lallemant
Journal:  J Clin Endocrinol Metab       Date:  2010-09-29       Impact factor: 5.958

Review 2.  Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls.

Authors:  Giuseppe Costante; Cosimo Durante; Zélia Francis; Martin Schlumberger; Sebastiano Filetti
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

Review 3.  Matrix metalloproteinases: multifunctional contributors to tumor progression.

Authors:  L J McCawley; L M Matrisian
Journal:  Mol Med Today       Date:  2000-04

Review 4.  Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment.

Authors:  Shabina R Ahmed; Douglas W Ball
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

5.  Extent of disease and practice patterns for medullary thyroid cancer.

Authors:  Electron Kebebew; Francis S Greenspan; Orlo H Clark; Kenneth A Woeber; Jocelyn Grunwell
Journal:  J Am Coll Surg       Date:  2005-06       Impact factor: 6.113

6.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen.

Authors:  L A Liotta; K Tryggvason; S Garbisa; I Hart; C M Foltz; S Shafie
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

Review 7.  Zinc and its role in immunity and inflammation.

Authors:  Paola Bonaventura; Giulia Benedetti; Francis Albarède; Pierre Miossec
Journal:  Autoimmun Rev       Date:  2014-11-24       Impact factor: 9.754

8.  Actions and interactions of thyroid hormone and zinc status in growing rats.

Authors:  H C Freake; K E Govoni; K Guda; C Huang; S A Zinn
Journal:  J Nutr       Date:  2001-04       Impact factor: 4.798

9.  Copper as ancillary diagnostic tool in preoperative evaluation of possible papillary thyroid carcinoma in patients with benign thyroid disease.

Authors:  Vesna V Dragutinović; Svetislav B Tatić; Snežana D Nikolić-Mandić; Tatjana M Tripković; Duško M Dunđerović; Ivan R Paunović
Journal:  Biol Trace Elem Res       Date:  2014-07-18       Impact factor: 3.738

Review 10.  Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism.

Authors:  J Olechnowicz; A Tinkov; A Skalny; Joanna Suliburska
Journal:  J Physiol Sci       Date:  2017-09-30       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.